ABUNDIA GLOBAL IMPACT GROUP, INC.·4

Feb 4, 4:39 PM ET

Henninger Matthew T. 4

4 · ABUNDIA GLOBAL IMPACT GROUP, INC. · Filed Feb 4, 2026

Research Summary

AI-generated summary of this filing

Updated

AGIG Director Matthew T. Henninger Receives Stock Option Award

What Happened
Matthew T. Henninger, a director of Abundia Global Impact Group, Inc. (AGIG), was granted a derivative award on 2026-02-03 covering 33,582 shares. The filing shows a transaction amount of $0.00 (no cash paid). This award was granted as compensation for board service rather than an open-market purchase or sale.

Key Details

  • Transaction date: 2026-02-03; Form 4 filed 2026-02-04 (timely under Form 4 rules).
  • Transaction type: Award/Grant of a derivative instrument for 33,582 shares; reported price $0.00.
  • Shares owned after transaction: Not specified in the filing.
  • Footnote: The option was granted as board compensation and vests quarterly over 12 months from the grant date. The reporting person disclaims beneficial ownership of the option and of any common shares issuable upon exercise until issuance under the issuer’s 2025 Equity Incentive Plan.
  • No indication of a cashless exercise, sale, or tax-withholding event in this filing.

Context
This is a compensation-related derivative grant (not an outright purchase or sale). Because the award vests over time and the insider disclaims beneficial ownership until issuance, these shares are not immediately tradeable and do not represent an immediate cash investment or liquidation by the insider. Compensation grants are common for board members and are informational rather than a direct signal of buy/sell intent.

Insider Transaction Report

Form 4
Period: 2026-02-03
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-02-03+33,58233,582 total
    Exercise: $2.68Exp: 2036-02-03Common Stock (33,582 underlying)
Footnotes (1)
  • [F1]Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.
Signature
/s/ Matthew T. Henninger|2026-02-04

Documents

1 file
  • 4
    ownership.xmlPrimary

    4